Impaired CAMK4 Activity Limits Atherosclerosis and Reprograms Myelopoiesis.
Sign Up to like & getrecommendations! Published in 2025 at "Arteriosclerosis, thrombosis, and vascular biology"
DOI: 10.1161/atvbaha.125.322530
Abstract: BACKGROUND Chronic inflammation is a major driver of atherosclerotic cardiovascular disease, and therapeutics that target inflammation reduce cardiac events beyond levels seen with strategies targeting cholesterol alone. RNA sequencing revealed increased expression of CaMK4 (calcium/calmodulin-dependent… read more here.
Keywords: atherosclerosis; camk4 monocytes; myelopoiesis; camk4 mice ... See more keywords